Intranasal Fentanyl for On-the-Hill Analgesia by Ski Patrol.

Wilderness Environ Med

University of Vermont Medical Center, Larner College of Medicine, University of Vermont, Burlington, VT.

Published: September 2022

Introduction: Intranasal fentanyl offers a means for safe and effective pain management in austere environments. Prehospital analgesia traditionally involves intravenous or intramuscular medication. However, for wilderness rescuers, these methods are often impractical.

Methods: We conducted a retrospective review of health records to evaluate the safety and efficacy of intranasal fentanyl administered by EMT-Basic certified ski patrollers. Our primary aim was to measure the reduction in initial pain scores to subsequent measurements at 5, 10, and 15 min using the pain numeric rating scale (0-10). Clinically significant reduction in severe pain has been established as ≥1.8 points. We used paired t-tests and multilevel modeling to measure statistical significance and potential interactions and reviewed patient charts for adverse events, including respiratory depression or the use of naloxone.

Results: We compiled the results from the winter seasons for 2007 through 2012 and 2016 through 2020. A total of 247 patients were included. The initial pain score was 8.6±1.5 (mean±SD). The decrease in pain scores from 0 to 5, 10, and 15 min, respectively, was -1.8, -2.4, and -2.9 (P<0.0001), which demonstrated a clinically and statistically significant decrease in pain scores. There were no adverse events.

Conclusions: Traditional standard of care analgesics are invasive, elongate scene times, and increase the risk of environmental exposure and provider needlestick. Intranasal fentanyl offers a safe, noninvasive, and rapid analgesia that is well-suited for austere winter environments, such as those encountered at ski resorts. This study demonstrates the safety and efficacy of the administration of intranasal fentanyl by EMT-Basic certified providers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wem.2022.05.003DOI Listing

Publication Analysis

Top Keywords

intranasal fentanyl
12
initial pain
8
pain scores
8
pain
6
fentanyl on-the-hill
4
on-the-hill analgesia
4
analgesia ski
4
ski patrol
4
patrol introduction
4
introduction intranasal
4

Similar Publications

Background: Xylazine is a α2-adrenergic receptor agonist, used for sedation in veterinary contexts. Although it is increasingly found in overdose deaths across North America, the clinical management of xylazine-involved overdoses has not been extensively studied, especially in community-based harm reduction settings. Here we present a clinical series of xylazine-involved overdose and share the clinical approach and lessons learned by a community overdose response team in Tijuana, Mexico amidst the arrival of xylazine.

View Article and Find Full Text PDF

Barriers and Enablers in Prehospital Pediatric Analgesia.

Prehosp Emerg Care

December 2024

Department of Emergency Medicine, Alpert Medical School, Brown University, Providence, Rhode Island.

Article Synopsis
  • Children represent a small percentage of EMS transports but often experience under-treatment of pain; this study examines factors influencing EMS clinicians' ability to provide effective prehospital pain management for pediatric patients.
  • Key enablers identified include longer transport times, the need to stabilize patients, and clinician familiarity with intranasal fentanyl, while barriers include concerns over patient stability, caregiver discomfort with pain medications, and limited pediatric experience among EMS staff.
  • Focus groups with EMS clinicians highlighted perspectives on pain management decision-making, available resources, and patient and family reactions, reaching thematic saturation in the analysis of both facilitators and obstacles in administering analgesia to children.
View Article and Find Full Text PDF

The increase in opioid overdose deaths, particularly involving potent, long-acting synthetic opioids, has led to calls for stronger, longer-acting opioid-overdose-reversal agents. Using an opioid-induced respiratory depression model, we investigated the onset and time course of action of naloxone and a long-acting opioid antagonist, nalmefene, in reversing the effects of an ongoing intravenous fentanyl infusion over a period of up to 100 min. Healthy, moderately experienced opioid users received intramuscular (IM) nalmefene 1 mg, IM naloxone 2 mg, or intranasal (IN) naloxone 4 mg after fentanyl-induced respiratory depression was established based on reduction in respiratory minute volume (MV).

View Article and Find Full Text PDF
Article Synopsis
  • A study looked at how safe and helpful it is to use nose sprays of certain medicines, fentanyl and midazolam, for kids in hospitals.
  • The study found that most kids received midazolam, and these medicines were often used when kids had to go through procedures like getting an IV or a lumbar puncture.
  • No serious side effects were reported, but the researchers say more studies should be done before using these medicines more widely in hospitals.
View Article and Find Full Text PDF

Objective: Intranasal (IN) fentanyl and nitrous oxide (NO) can be combined to provide procedural sedation and analgesia to children. This combination is advantageous because of rapid onset of action and non-parenteral administration, but is associated with increased vomiting. We sought to describe the associations of demographic and procedural factors with early vomiting when using this combination in children.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!